rs3735943
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_007332.3(TRPA1):c.1630C>T(p.Leu544Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.51 in 1,609,828 control chromosomes in the GnomAD database, including 212,152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.52 ( 20935 hom., cov: 32)
Exomes 𝑓: 0.51 ( 191217 hom. )
Consequence
TRPA1
NM_007332.3 synonymous
NM_007332.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.73
Genes affected
TRPA1 (HGNC:497): (transient receptor potential cation channel subfamily A member 1) The structure of the protein encoded by this gene is highly related to both the protein ankyrin and transmembrane proteins. The specific function of this protein has not yet been determined; however, studies indicate the function may involve a role in signal transduction and growth control. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 8-72053767-G-A is Benign according to our data. Variant chr8-72053767-G-A is described in ClinVar as [Benign]. Clinvar id is 1342282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.73 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.673 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.519 AC: 78883AN: 151914Hom.: 20901 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
78883
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.554 AC: 138305AN: 249818 AF XY: 0.545 show subpopulations
GnomAD2 exomes
AF:
AC:
138305
AN:
249818
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.509 AC: 741460AN: 1457796Hom.: 191217 Cov.: 34 AF XY: 0.508 AC XY: 368715AN XY: 725228 show subpopulations
GnomAD4 exome
AF:
AC:
741460
AN:
1457796
Hom.:
Cov.:
34
AF XY:
AC XY:
368715
AN XY:
725228
Gnomad4 AFR exome
AF:
AC:
16603
AN:
33376
Gnomad4 AMR exome
AF:
AC:
32304
AN:
44560
Gnomad4 ASJ exome
AF:
AC:
14091
AN:
26104
Gnomad4 EAS exome
AF:
AC:
26619
AN:
39674
Gnomad4 SAS exome
AF:
AC:
47775
AN:
86004
Gnomad4 FIN exome
AF:
AC:
27755
AN:
53324
Gnomad4 NFE exome
AF:
AC:
542478
AN:
1109782
Gnomad4 Remaining exome
AF:
AC:
31415
AN:
60144
Heterozygous variant carriers
0
18651
37302
55952
74603
93254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
16030
32060
48090
64120
80150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.519 AC: 78966AN: 152032Hom.: 20935 Cov.: 32 AF XY: 0.524 AC XY: 38936AN XY: 74316 show subpopulations
GnomAD4 genome
AF:
AC:
78966
AN:
152032
Hom.:
Cov.:
32
AF XY:
AC XY:
38936
AN XY:
74316
Gnomad4 AFR
AF:
AC:
0.499566
AN:
0.499566
Gnomad4 AMR
AF:
AC:
0.637436
AN:
0.637436
Gnomad4 ASJ
AF:
AC:
0.531682
AN:
0.531682
Gnomad4 EAS
AF:
AC:
0.691712
AN:
0.691712
Gnomad4 SAS
AF:
AC:
0.570449
AN:
0.570449
Gnomad4 FIN
AF:
AC:
0.504064
AN:
0.504064
Gnomad4 NFE
AF:
AC:
0.490184
AN:
0.490184
Gnomad4 OTH
AF:
AC:
0.520873
AN:
0.520873
Heterozygous variant carriers
0
1912
3824
5735
7647
9559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2227
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Familial episodic pain syndrome with predominantly upper body involvement Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=97/3
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at